Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BNTX | ALNY | ILMN | ||
| Company | Biontech Se ADR | Alnylam Pharmaceuticals | Illumina Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 110.76 | 239.45 | 133.45 | ||
| High | 115.34 | 247.21 | 137.69 | ||
| Low | 109.80 | 235.93 | 133.08 | ||
| Last | 113.08 | 245.44 | 136.02 | ||
| Change | +1.74 | +6.57 | +2.02 | ||
| % Change | +1.56% | +2.75% | +1.51% | ||
| Volume | 924,900 | 1,663,500 | 14,354,300 | ||
| 20-Day Average Volume | 790,130 | 671,405 | 2,365,830 | ||
| Previous Close | 111.34 | 238.87 | 134.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 117.27 | 249.56 | 142.51 | ||
| 20-Day Raw Stochastic | 31.52% | 48.68% | 26.63% | ||
| 20-Day Relative Strength | 49.19% | 43.51% | 44.22% | ||
| Weighted Alpha | -1.65 | +7.65 | +1.44 | ||
| Today's Opinion | 72% Buy | 8% Sell | 24% Buy | ||
| Previous Opinion | 72% Buy | 24% Sell | 24% Buy | ||
| Last Month's Opinion | 40% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.06% since 12/13/24 | unch since 12/13/24 | -5.46% since 12/13/24 | ||
| Low | 109.52 on 12/19/24 | 233.41 on 12/19/24 | 130.31 on 12/19/24 | ||
| High | 119.64 on 12/16/24 | 249.58 on 12/17/24 | 148.51 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +10.71% since 11/20/24 | -1.35% since 11/20/24 | +3.30% since 11/20/24 | ||
| Low | 101.26 on 11/21/24 | 233.41 on 12/19/24 | 130.11 on 11/21/24 | ||
| High | 125.40 on 12/06/24 | 258.12 on 12/09/24 | 151.75 on 12/10/24 | ||
| 3-Month | |||||
| %Chg | +0.71% since 09/20/24 | -10.38% since 09/20/24 | +3.67% since 09/20/24 | ||
| Low | 94.31 on 11/15/24 | 229.85 on 11/18/24 | 125.06 on 10/01/24 | ||
| High | 125.40 on 12/06/24 | 304.39 on 10/17/24 | 156.66 on 11/05/24 | ||
| 6-Month | |||||
| %Chg | +31.67% since 06/20/24 | +55.93% since 06/20/24 | +25.65% since 06/20/24 | ||
| Low | 76.53 on 08/05/24 | 158.38 on 06/21/24 | 103.52 on 06/28/24 | ||
| High | 131.49 on 09/17/24 | 304.39 on 10/17/24 | 156.66 on 11/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,882,056 | 31,657,098 | 21,572,772 | ||
| Shares Outstanding, K | 237,726 | 128,981 | 158,600 | ||
| Annual Sales | 4,133,300,000 | 1,828,290,000 | 4,504,000,000 | ||
| Annual Net Income | 1,006,860,000 | -440,240,000 | -1,161,000,000 | ||
| Last Quarter Sales | 1,368,780,000 | 500,920,000 | 1,080,000,000 | ||
| Last Quarter Net Income | 217,830,000 | -111,570,000 | 705,000,000 | ||
| 60-Month Beta | 0.22 | 0.32 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 11/04/24 | -0.50 on 10/31/24 | 1.14 on 11/04/24 | ||
| Latest Earnings Date | 11/04/24 | 10/31/24 | 02/13/25 | ||
| Most Recent Dividend | 3.084 on 06/02/22 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/02/22 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 77.46 | ||